LOUISVILLE, CO, January 10, 2006, GlobeImmune, Inc., today announced the final closing of a Series B Preferred Stock financing. GlobeImmune added an additional $4.1 million to the previously announced first close of $34.3 million, bringing the total amount raised in … Continue reading
GlobeImmune secures additional $4.1 million and closes Series B financing with a total of $38.4 million raised
January 10, 2006
